Lei-Jie Dai

3PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Aug 26, 2024
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies.

Yu-Wei Li, Lei-Jie Dai, Xiang-Rong Wu

|Feb 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.

Yi-Zhou Jiang, Ding Ma, Xi Jin

|Aug 22, 2023
Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer.

Lei-Jie Dai, Ding Ma, Yu-Zheng Xu

Pageof 1

Frequent Collaborators

3 joint publications

Ding Ma

3 joint publications

Wen-Tao Yang

3 joint publications

Zhi-Ming Shao

2 joint publications

Ming Li

2 joint publications

Yi-Zhou Jiang

1 joint publications

Ying Yu

1 joint publications

Yaqing Liu

1 joint publications

Qingwang Chen

1 joint publications

François Bertucci

1 joint publications

Nakul M Shah

Frequent Collaborators

3 joint publications

Ding Ma

3 joint publications

Wen-Tao Yang

3 joint publications

Zhi-Ming Shao

2 joint publications

Ming Li

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

12.6K
Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

1.5K
See more related videos

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

12.6K
Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

1.5K
See more related videos